These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 7780978)

  • 1. Uptake, localization, and photodynamic effect of meso-tetra(hydroxyphenyl)porphine and its corresponding chlorin in normal and tumor tissues of mice bearing mammary carcinoma.
    Peng Q; Moan J; Ma LW; Nesland JM
    Cancer Res; 1995 Jun; 55(12):2620-6. PubMed ID: 7780978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor effect of 5-aminolevulinic acid-mediated photodynamic therapy can be enhanced by the use of a low dose of photofrin in human tumor xenografts.
    Peng Q; Warloe T; Moan J; Godal A; Apricena F; Giercksky KE; Nesland JM
    Cancer Res; 2001 Aug; 61(15):5824-32. PubMed ID: 11479222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of a tri-glucoconjugated 5,10,15-(meta)-trihydroxyphenyl-20-phenyl porphyrin photosensitizer for PDT. A single dose study in the rat.
    Desroches MC; Bautista-Sanchez A; Lamotte C; Labeque B; Auchère D; Farinotti R; Maillard P; Grierson DS; Prognon P; Kasselouri A
    J Photochem Photobiol B; 2006 Oct; 85(1):56-64. PubMed ID: 16765603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. m-THPC-mediated photodynamic therapy (PDT) does not induce resistance to chemotherapy, radiotherapy or PDT on human breast cancer cells in vitro.
    Hornung R; Walt H; Crompton NE; Keefe KA; Jentsch B; Perewusnyk G; Haller U; Köchli OR
    Photochem Photobiol; 1998 Oct; 68(4):569-74. PubMed ID: 9796440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Photodynamic treatment as a novel approach in the therapy of arthritic joints.
    Hansch A; Frey O; Gajda M; Susanna G; Boettcher J; Bräuer R; Kaiser WA
    Lasers Surg Med; 2008 Apr; 40(4):265-72. PubMed ID: 18412224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved in vivo delivery of m-THPC via pegylated liposomes for use in photodynamic therapy.
    Bovis MJ; Woodhams JH; Loizidou M; Scheglmann D; Bown SG; Macrobert AJ
    J Control Release; 2012 Jan; 157(2):196-205. PubMed ID: 21982898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term regression of the murine mammary adenocarcinoma, LM3, by repeated photodynamic treatments using meso-tetra (4-N-methylpyridinium) porphine.
    Colombo LL; Vanzulli SI; Villanueva A; Cañete M; Juarranz A; Stockert JC
    Int J Oncol; 2005 Oct; 27(4):1053-9. PubMed ID: 16142323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of distribution of sulphonated aluminium phthalocyanines with their photodynamic effect in tumour and skin of mice bearing CaD2 mammary carcinoma.
    Peng Q; Moan J
    Br J Cancer; 1995 Sep; 72(3):565-74. PubMed ID: 7669563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimizing photodynamic therapy: in vivo pharmacokinetics of liposomal meta-(tetrahydroxyphenyl)chlorin in feline squamous cell carcinoma.
    Buchholz J; Kaser-Hotz B; Khan T; Rohrer Bley C; Melzer K; Schwendener RA; Roos M; Walt H
    Clin Cancer Res; 2005 Oct; 11(20):7538-44. PubMed ID: 16243829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Photodynamic effects of SIM01, a new sensitizer, on experimental brain tumors in rats.
    Olivier D; Bourré L; El-Sabbagh E; Loussouarn D; Simonneaux G; Valette F; Patrice T
    Surg Neurol; 2007 Sep; 68(3):255-63; discussion 263. PubMed ID: 17544487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of delta-aminolevulinic acid-induced protoporphyrin as a photosensitizer for photodynamic therapy in vivo.
    Hua Z; Gibson SL; Foster TH; Hilf R
    Cancer Res; 1995 Apr; 55(8):1723-31. PubMed ID: 7712481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for different mechanisms of EMT-6 tumor necrosis by photodynamic therapy with disulfonated aluminum phthalocyanine or photofrin: tumor cell survival and blood flow.
    Chan WS; Brasseur N; La Madeleine C; van Lier JE
    Anticancer Res; 1996; 16(4A):1887-92. PubMed ID: 8712717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant intraoperative photodynamic therapy in experimental colorectal cancer using a new photosensitizer.
    Abulafi AM; DeJode ML; Allardice JT; Ansell JK; Williams NS
    Br J Surg; 1997 Mar; 84(3):368-71. PubMed ID: 9117310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic properties and photosensitizing responsiveness of mono-L-aspartyl chlorin e6 in a mouse tumor model.
    Ferrario A; Kessel D; Gomer CJ
    Cancer Res; 1992 May; 52(10):2890-3. PubMed ID: 1581904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative study of 28 porphyrins and their abilities to localize in mammary mouse carcinoma: uroporphyrin I superior to hematoporphyrin derivative.
    El-Far M; Pimstone N
    Prog Clin Biol Res; 1984; 170():661-72. PubMed ID: 6241706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effective treatment of liver metastases with photodynamic therapy, using the second-generation photosensitizer meta-tetra(hydroxyphenyl)chlorin (mTHPC), in a rat model.
    Rovers JP; Saarnak AE; Molina A; Schuitmaker JJ; Sterenborg HJ; Terpstra OT
    Br J Cancer; 1999 Oct; 81(4):600-8. PubMed ID: 10574244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of tetra(m-hydroxyphenyl)chlorin in human plasma and individualized light dosimetry in photodynamic therapy.
    Glanzmann T; Hadjur C; Zellweger M; Grosiean P; Forrer M; Ballini JP; Monnier P; van den Bergh H; Lim CK; Wagnières G
    Photochem Photobiol; 1998 May; 67(5):596-602. PubMed ID: 9613244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Photodynamic therapy for early squamous cell carcinomas of the esophagus, bronchi, and mouth with m-tetra (hydroxyphenyl) chlorin.
    Savary JF; Monnier P; Fontolliet C; Mizeret J; Wagnières G; Braichotte D; van den Bergh H
    Arch Otolaryngol Head Neck Surg; 1997 Feb; 123(2):162-8. PubMed ID: 9046283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Photodynamic therapy with mTHPC and polyethylene glycol-derived mTHPC: a comparative study on human tumour xenografts.
    Ris HB; Krueger T; Giger A; Lim CK; Stewart JC; Althaus U; Altermatt HJ
    Br J Cancer; 1999 Mar; 79(7-8):1061-6. PubMed ID: 10098737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Highly selective targeting of ovarian cancer with the photosensitizer PEG-m-THPC in a rat model.
    Hornung R; Fehr MK; Monti-Frayne J; Krasieva TB; Tromberg BJ; Berns MW; Tadir Y
    Photochem Photobiol; 1999 Oct; 70(4):624-9. PubMed ID: 10546556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.